Advanced Search

Study Preview



Study Title and Description

Treatment of established postmenopausal osteoporosis with raloxifene: a randomized trial.



Key Questions Addressed
3 Key Question 3. What are the harms of using medications to reduce risk for primary breast cancer? Key Question 3a. Do harms of risk-reducing medications vary by timing of initiation and/or duration of use? Key Question 3b. Do harms of risk-reducing medications persist beyond discontinuation of use?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Treatment of established postmenopausal osteoporosis with raloxifene: a randomized trial.
Author Lufkin EG., Whitaker MD., Nickelsen T., Argueta R., Caplan RH., Knickerbocker RK., Riggs BL.
Country Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota 55905, USA.
Year 1998
Numbers Pubmed ID: 9797484

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-4


Results & Comparisons

No Results found.